Deerfield Management’s Wave Life Sciences WVE Stock Holding History

Deerfield Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-552,690	Closed	-$1.74M	–	133
2021 Q4	$1.74M	Sell	552,690 -2,661,650	-83%	-$11.1M	0.04%	110
2021 Q3	$15.8M	Sell	3,214,340 -1,614,729	-33%	-$9.79M	0.31%	78
2021 Q2	$32.2M	Buy	4,829,069 +1,326,099	+38%	+$8.66M	0.57%	56
2021 Q1	$19.7M	Buy	+3,502,970	New	+$33.7M	0.41%	74
2019 Q4	–	Sell	-807,727	Closed	-$16.6M	–	95
2019 Q3	$16.6M	Buy	807,727 +138,467	+21%	+$3.17M	0.68%	45
2019 Q2	$17.5M	Buy	669,260 +274,523	+70%	+$7.7M	0.63%	56
2019 Q1	$15.3M	Buy	+394,737	New	+$16M	0.59%	50
2018 Q3	–	Sell	-178,806	Closed	-$6.84M	–	115
2018 Q2	$6.84M	Sell	178,806 -89,368	-33%	-$3.85M	0.24%	90
2018 Q1	$10.8M	Sell	268,174 -46,500	-15%	-$1.95M	0.37%	82
2017 Q4	$11M	Sell	314,674 -265,326	-46%	-$7.74M	0.43%	64
2017 Q3	$12.6M	Sell	580,000 -166,841	-22%	-$3.35M	0.57%	57
2017 Q2	$13.9M	Buy	746,841 +274,717	+58%	+$5.92M	0.74%	39
2017 Q1	$13M	Hold	472,124	–	–	0.5%	59
2016 Q4	$12.3M	Buy	+472,124	New	+$15.4M	0.51%	57

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Deerfield Management's WVE Position: Q1 2022 in Review

Deerfield Management sold out of Wave Life Sciences (WVE) in Q1 2022, closing a stake of 552,690 shares — an estimated $1.74M sold.

Deerfield Management first reported a position in WVE in Q4 2016 and held it in 14 quarters. The position peaked at $32.2M in Q2 2021. 82 funds tracked by Wall St. Rank hold WVE as of Q1 2022.

Deerfield Management reported no remaining Wave Life Sciences position as of Q1 2022 after selling out during the quarter.
Deerfield Management sold 552,690 Wave Life Sciences shares in Q1 2022, an estimated $1.74M.
Deerfield Management first reported a position in Wave Life Sciences in Q4 2016 and held it in 14 quarters.
Deerfield Management's Wave Life Sciences position peaked at $32.2M in Q2 2021.
82 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2022.

Based on Deerfield Management's 13F filing for Q1 2022, filed 16 May 2022.